IRIS UniCatt

Basso, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.947
AS - Asia 1.951
EU - Europa 1.914
SA - Sud America 326
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 7.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.868
SG - Singapore 952
DE - Germania 664
CN - Cina 394
SE - Svezia 315
IT - Italia 282
BR - Brasile 252
VN - Vietnam 232
FR - Francia 135
GB - Regno Unito 89
FI - Finlandia 84
IN - India 83
UA - Ucraina 72
IE - Irlanda 64
ID - Indonesia 49
JP - Giappone 45
RU - Federazione Russa 45
HK - Hong Kong 44
CA - Canada 42
PL - Polonia 39
AR - Argentina 33
TR - Turchia 32
BD - Bangladesh 30
BE - Belgio 25
CI - Costa d'Avorio 23
MX - Messico 23
NL - Olanda 22
ZA - Sudafrica 18
EC - Ecuador 17
IQ - Iraq 16
AT - Austria 15
ES - Italia 14
IR - Iran 13
PK - Pakistan 11
SA - Arabia Saudita 10
CZ - Repubblica Ceca 8
LT - Lituania 8
CO - Colombia 7
VE - Venezuela 7
GR - Grecia 6
KR - Corea 6
RO - Romania 5
AE - Emirati Arabi Uniti 4
MA - Marocco 4
PH - Filippine 4
PY - Paraguay 4
TN - Tunisia 4
UZ - Uzbekistan 4
AU - Australia 3
CL - Cile 3
CR - Costa Rica 3
DZ - Algeria 3
KE - Kenya 3
PE - Perù 3
SN - Senegal 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.208
Salva come PNG Salva come JPEG
Città #
Ashburn 708
Singapore 606
Chandler 332
San Jose 214
Beijing 77
New York 74
Los Angeles 71
Hanoi 67
Rome 67
Ho Chi Minh City 66
Dublin 63
Ann Arbor 52
San Mateo 52
Wilmington 52
Helsinki 51
Dallas 47
Chicago 46
The Dalles 46
Cattolica 45
Lauterbourg 43
Jacksonville 42
Munich 42
Tokyo 42
Jakarta 41
Nanjing 41
Boston 36
Warsaw 35
Hong Kong 34
Nürnberg 33
Council Bluffs 29
Dearborn 29
Woodbridge 28
Frankfurt am Main 27
Milan 27
Moscow 27
Fairfield 26
Princeton 26
Santa Clara 25
Brussels 24
Matera 24
Abidjan 23
Houston 23
Orem 22
Hefei 21
Hyderabad 21
Nanchang 21
São Paulo 21
Marseille 20
Shanghai 20
Redwood City 19
Izmir 18
Seattle 18
Boardman 16
Denver 16
Augusta 14
Montreal 14
Redmond 14
Bremen 13
Hangzhou 13
Falls Church 12
Johannesburg 12
Paris 12
Amsterdam 11
Changsha 11
Da Nang 11
Phoenix 11
Stockholm 11
Brooklyn 10
Chennai 10
Guangzhou 10
Lawrence 10
Leawood 10
Mexico City 10
Nuremberg 10
Poplar 10
St Louis 10
Toronto 10
Turku 10
Buffalo 9
Hebei 9
Kent 9
London 9
Mountain View 9
Mumbai 9
Norwalk 9
Atlanta 8
Cambridge 8
Guayaquil 8
Campinas 7
Lappeenranta 7
Zhengzhou 7
Ankara 6
Jeddah 6
Potenza 6
Rio de Janeiro 6
San Francisco 6
Vienna 6
Washington 6
Baghdad 5
Bari 5
Totale 4.125
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 614
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 320
A phase II study of sunitinib in advanced hepatocellular carcinoma 269
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 236
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 234
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 208
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study 198
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 192
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 190
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 182
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 181
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 160
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 158
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib 157
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 156
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 151
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 150
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 149
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 148
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 147
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 146
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 144
Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma 139
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 139
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 137
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 135
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 130
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 129
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 128
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 125
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 124
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 123
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 121
Novel epigenetic eight-gene signature predictive of poor prognosis and msi-like phenotype in human metastatic colorectal carcinomas 116
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 113
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 112
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 111
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 106
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 103
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 99
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 94
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 86
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 84
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 83
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 81
Targeted therapy in advanced gastric carcinoma: The future is beginning 73
New life for retrospective study in the precision oncology era 67
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 59
Totale 7.307
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202144 0 0 0 0 0 0 0 0 0 0 38 6
2021/2022453 37 16 12 64 27 11 7 68 17 37 61 96
2022/2023926 124 125 82 168 42 108 48 76 75 25 32 21
2023/2024862 20 90 28 14 12 71 236 263 2 16 38 72
2024/2025862 16 39 71 37 76 37 33 37 93 96 166 161
2025/20262.825 334 87 187 447 636 155 480 137 195 155 12 0
Totale 7.307